"One Blood. One Activation." explained simply
Quick answer
EUPOTON (also spelled Euphoton or Uphoton) is NUMATRON's autologous blood stem-cell activation system. About 150 cc of the patient's own blood goes through the 5-stage AKI CELL protocol — oxygen → UVC light → centrifugation → UVA light → secretome — and the activated fractions are returned to the body without chemical activators.
EUPOTON's core idea is "regeneration begins within". The manufacturer explains that blood already carries repair tools — stem cells, growth factors, platelets and guiding signals — so the system activates the patient's own cells and plasma secretome rather than introducing donor cells.
The process starts with 150 cc of blood and runs five consecutive stages, each the starting condition for the next. The manufacturer calls this cumulative activation and uses an Activation Potential Index that rises 4×, 8× and 16× across stages 2–4.
The heart of the device is the Smart M-Cell module, which runs an automated dual-spin centrifugation and uses four-colour LED light (blue, green, yellow, red). Platelets are activated by light instead of chemicals, which the manufacturer says is repeatable with minimal side effects.
This series covers each topic in turn: the AKI CELL stages, the activation index, centrifugation, LED light, blood components, the secretome, comparisons with PRP/HemaPure/MSC, lab data and what to know before deciding.
Note: this article summarises the manufacturer's materials. Lab figures are in-vitro results, not human treatment outcomes, and nothing here is medical advice. Clinical use follows local approvals and physician judgment. For the overview, see What is EUPOTON.
Yes. They are spellings of the same name: the manufacturer's deck uses EUPOTON, the EN600NT device panel reads EUPHOTON, and people also search for Uphoton.
Only the patient's own — it starts and ends with the same patient's 150 cc of blood.
According to the manufacturer, no — platelets are activated with red LED light instead.
NUMATRON (Medical Biochemistry); more at eupoton.com.
The manufacturer presents it as activating a regenerative environment from the patient's own blood. Its materials do not show proof of curing any specific disease in humans, so ask a physician for clinical evidence first.
5 points • reviewed 2026-11-08
Reviewed and last updated: 2026-11-08
4 sources • every claim is traceable
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-11-08 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories